Multi-strain Bifidobacteria Composition for C-Section Infant Gut Biodiversity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Infants delivered via caesarean section have a distinctively different intestinal flora profile compared to those born vaginally, lacking essential Bifidobacteria species and exhibiting reduced biodiversity, which affects their immune system development and infection resistance.
Innovation Solution
A composition comprising at least three different Bifidobacterium species (Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium catenulatum, and Bifidobacterium adolescentis) along with indigestible oligosaccharides is administered to infants born via caesarean section to enhance the biodiversity and growth of beneficial microorganisms in their intestinal flora.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If infant formulae contain only one or two Bifidobacteria species (like Life Start® with Bifidobacterium infantis), then the product is simple to manufacture and administer, but the biodiversity of intestinal flora is insufficient and health benefits are limited
Solution Approach 1:
The patent combines multiple Bifidobacteria species (at least three different species including B. breve, B. infantis, B. bifidum, B. catenulatum, B. adolescentis, and B. longum) into a single probiotic composition. This merging of multiple beneficial bacteria strains works synergistically to colonize the infant gut and establish diverse intestinal flora, thereby resolving the contradiction between product simplicity and biodiversity effectiveness.
Solution Approach 2:
The invention creates a composite probiotic product containing multiple Bifidobacteria species along with prebiotic oligosaccharides. This composite formulation provides both probiotic bacteria and their food source, enabling the bacteria to thrive and establish in the infant gut. The composite nature of the product simultaneously achieves manufacturing feasibility and high biodiversity benefit.
2Ease of manufacture
If infants delivered via caesarean section receive standard infant formula or single-strain probiotics, then the formula is easy to produce and distribute, but the infants' intestinal flora remains deficient in essential Bifidobacteria species
Solution Approach 1:
The patent tailors the probiotic composition specifically for caesarean-delivered infants by including at least three Bifidobacteria species that are particularly beneficial for this group. The formulation is locally optimized for the specific needs of c-section infants whose intestinal flora development is compromised by the delivery method, rather than using a one-size-fits-all approach.
Solution Approach 2:
The probiotic composition is administered to c-section infants as early as possible after birth to preliminarily establish beneficial Bifidobacteria in the gut before harmful bacteria can dominate. This preliminary action compensates for the delayed natural colonization that occurs in c-section infants, ensuring reliable intestinal flora development from the outset.
3Adaptability or versatility
If infants receive breast milk alone, then the nutrition is natural and optimal, but the intestinal flora biodiversity is insufficient in caesarean-delivered infants
Solution Approach 1:
The probiotic composition acts as an intermediary supplement that can be added to breast milk to enhance its beneficial effects. The composition includes prebiotic oligosaccharides that work synergistically with breast milk components to promote Bifidobacteria growth, thereby maintaining the naturalness of breastfeeding while compensating for the biodiversity deficiency in c-section infants.
Solution Approach 2:
The invention modifies the microbial parameter of breast milk by adding multiple Bifidobacteria species and prebiotics, transforming ordinary breast milk into an enhanced formulation that actively promotes diverse intestinal flora development. This parameter change allows breast milk to simultaneously maintain its natural adaptability and provide enhanced biodiversity benefits.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively increases the biodiversity of the intestinal flora and stimulates the healthy development of beneficial microorganisms, improving the immune system and infection resistance in infants born via caesarean section, even when breastfed.
Implementation Method 1
at least three different Bifidobacterium species... stimulate the healthy development of the intestinal flora
Implementation Method 2
prebiotic fibers... selectively stimulate the growth of beneficial bacteria in colon
Data Source
AI summary
The present invention relates to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two, preferably three, different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.